What We're Reading: Page 278
Industry reads hand-picked by our editors
Feb 14, 2018
-
Bloomberg
What stands between Bezos, Buffett, and Dimon and a health-care fix
-
Associated Press
Can gene therapy be harnessed to fight the AIDS virus?
-
Quartz
This year’s dismal flu season is helping pharmacy stocks
-
GeekWire
Pittsburgh research giants unveil landmark $200M immunotherapy center to combat cancer and aging
-
Merck & Co.
Merck delivers latest Alzheimer's disappointment
Feb 13, 2018
-
Undark
If a pharma company publishes a magazine, is it journalism?
-
The Washington Post
Former pharma exec, Christie backer seeks to oust Menendez
-
Reuters
Germany's CureVac wins new vaccine funding from Gates Foundation
-
The New York Times
He took a drug to prevent AIDS. Then he couldn’t get disability insurance.
Feb 12, 2018
-
The New York Times
F.D.A. chief goes against the administration stereotype
-
FT
Amgen 'looking hard' at striking deals using $27B cash pile
-
The Denver Post
CEO of Colorado biotech-turned-blockchain company explains why he sold stock after price quadrupled
-
The Boston Globe
Japanese executives ponder investing in Mass.
Feb 09, 2018
Feb 08, 2018
Feb 07, 2018
Feb 06, 2018
-
Reuters
In diabetes war, Novo Nordisk aims to break mold with new pill
-
Financial Times
How DNA could store all the world’s data in a semi-trailer
-
MIT Technology Review
A biotech CEO explains why he injected himself with a DIY herpes treatment live on stage
-
The Wall Street Journal
Why Sanofi and its rivals are paying up for deals
Previous
